NASDAQ:CGNX - Cognex Stock Price, Price Target & More

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex announced a quarterly dividend on Monday, April 30th. Shareholders of record on Friday, May 18th will be given a dividend of $0.045 per share on Friday, June 1st. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Thursday, May 17th. View Cognex's Dividend History.

Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly issued shares were distributed to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex declared that its Board of Directors has approved a share repurchase program on Friday, February 16th 2018, which authorizes the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company's management believes its stock is undervalued.

Cognex Co. (NASDAQ:CGNX) announced its quarterly earnings results on Thursday, February, 15th. The scientific and technical instruments company reported $0.30 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.25 by $0.05. The scientific and technical instruments company had revenue of $180.37 million for the quarter, compared to the consensus estimate of $178.75 million. Cognex had a return on equity of 23.08% and a net margin of 21.56%. The business's quarterly revenue was up 39.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.20 EPS. View Cognex's Earnings History.

Cognex is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Cognex.

9 equities research analysts have issued 1 year price objectives for Cognex's shares. Their forecasts range from $40.00 to $80.00. On average, they expect Cognex's share price to reach $57.4167 in the next twelve months. This suggests a possible upside of 28.0% from the stock's current price. View Analyst Ratings for Cognex.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cognex include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Orbotech (ORBK), Esterline Technologies (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), Sypris Solutions (SYPR), Elbit Vision Systems (EVSNF) and International Isotopes (INIS).

News stories about CGNX stock have trended somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cognex earned a news sentiment score of 0.04 on Accern's scale. They also gave news stories about the scientific and technical instruments company an impact score of 48.56 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Cognex's stock is owned by a variety of of institutional and retail investors. Top institutional investors include American Capital Management Inc. (0.93%), Fred Alger Management Inc. (0.70%), Handelsbanken Fonder AB (0.32%), Welch & Forbes LLC (0.24%), Riverbridge Partners LLC (0.21%) and Westpac Banking Corp (0.05%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Richard Morin, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.

CGNX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Essex Investment Management Co. LLC, Sit Investment Associates Inc., Municipal Employees Retirement System of Michigan and Riverbridge Partners LLC. Company insiders that have sold Cognex company stock in the last year include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Insider Buying and Selling for Cognex.

CGNX stock was bought by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Welch & Forbes LLC, Bellecapital International Ltd., DnB Asset Management AS, Pennsylvania Trust Co, Exane Derivatives, Bank of Montreal Can and Nisa Investment Advisors LLC. View Insider Buying and Selling for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $44.87.

Cognex has a market capitalization of $7.88 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]